AAAAAA

   
Results: 1-11 |
Results: 11
Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro
Authors: Miu, P Jarvie, KR Radhakrishnan, V Gates, MR Ogden, A Ornstein, PL Zarrinmayeh, H Ho, K Peters, D Grabell, J Gupta, A Zimmerman, DM Bleakman, D
Citation: P. Miu et al., Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro, NEUROPHARM, 40(8), 2001, pp. 976-983
[H-3]N-2-(4-(N-benzamido)phenyl)propyl-2-propanesulfonamide: A novel AMPA receptor potentiates and radioligand
Authors: Zarrinmayeh, H Bleakman, D Gates, MR Yu, H Zimmerman, DM Ornstein, PL McKennon, T Arnold, MB Wheeler, WJ Skolnick, P
Citation: H. Zarrinmayeh et al., [H-3]N-2-(4-(N-benzamido)phenyl)propyl-2-propanesulfonamide: A novel AMPA receptor potentiates and radioligand, J MED CHEM, 44(3), 2001, pp. 302-304
Identification of the first trans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity
Authors: Thomas, JB Atkinson, RN Rothman, RB Fix, SE Mascarella, SW Vinson, NA Xu, H Dersch, CM Lu, YF Cantrell, BE Zimmerman, DM Carroll, FI
Citation: Jb. Thomas et al., Identification of the first trans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity, J MED CHEM, 44(17), 2001, pp. 2687-2690
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone
Authors: Yue, TL Chen, J Bao, WK Narayanan, PK Bril, A Jiang, W Lysko, PG Gu, JL Boyce, R Zimmerman, DM Hart, TK Buckingham, RE Ohlstein, EH
Citation: Tl. Yue et al., In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone, CIRCULATION, 104(21), 2001, pp. 2588-2594
Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)-propanoic acid (AMPA) receptors
Authors: Ornstein, PL Zimmerman, DM Arnold, MB Bleisch, TJ Cantrell, B Simon, R Zarrinmayeh, H Baker, SR Gates, M Tizzano, JP Bleakman, D Mandelzys, A Jarvie, KR Ho, K Deverill, M Kamboj, RK
Citation: Pl. Ornstein et al., Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)-propanoic acid (AMPA) receptors, J MED CHEM, 43(23), 2000, pp. 4354-4358
Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists
Authors: Zarrinmayeh, H Zimmerman, DM Cantrell, BE Schober, DA Bruns, RF Gackenheimer, SL Ornstein, PL Hipskind, PA Britton, TC Gehlert, DR
Citation: H. Zarrinmayeh et al., Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists, BIOORG MED, 9(5), 1999, pp. 647-652
Structure-activity relationships of a series of benzothiophene-derived NPYY1 antagonists: Optimization of the C-2 side chain
Authors: Britton, TC Spinazze, PG Hipskind, PA Zimmerman, DM Zarrinmayeh, H Schober, DA Gehlert, DR Bruns, RF
Citation: Tc. Britton et al., Structure-activity relationships of a series of benzothiophene-derived NPYY1 antagonists: Optimization of the C-2 side chain, BIOORG MED, 9(3), 1999, pp. 475-480
A stereoselective synthetic approach to N-alkyl-4 beta-methyl-5-phenylmorphans
Authors: Thomas, JB Gigstad, KM Fix, SE Burgess, JP Cooper, JB Mascarella, SW Cantrell, BE Zimmerman, DM Carroll, FI
Citation: Jb. Thomas et al., A stereoselective synthetic approach to N-alkyl-4 beta-methyl-5-phenylmorphans, TETRAHEDR L, 40(3), 1999, pp. 403-406
Rapid parallel synthesis applied to the optimization of a series of potentnonpeptide neuropeptide Y-1 receptor antagonists
Authors: Siegel, MG Chaney, MO Bruns, RF Clay, MP Schober, DA Van Abbema, AM Johnson, DW Cantrell, BE Hahn, PJ Hunden, DC Gehlert, DR Zarrinmayeh, H Ornstein, PL Zimmerman, DM Koppel, GA
Citation: Mg. Siegel et al., Rapid parallel synthesis applied to the optimization of a series of potentnonpeptide neuropeptide Y-1 receptor antagonists, TETRAHEDRON, 55(39), 1999, pp. 11619-11639
N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methylbenzo[g]isoquinolines are opioid receptor pure antagonists
Authors: Thomas, JB Mascarella, SW Burgess, JP Xu, H McCullough, KB Rothman, RB Flippen-Anderson, JL George, CF Cantrell, BE Zimmerman, DM Carroll, FY
Citation: Jb. Thomas et al., N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methylbenzo[g]isoquinolines are opioid receptor pure antagonists, BIOORG MED, 8(22), 1998, pp. 3149-3152
Identification of an opioid kappa receptor subtype-selective N-substituentfor (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine
Authors: Thomas, JB Fall, MJ Cooper, JB Rothman, RB Mascarella, SW Xu, H Partilla, JS Dersch, CM McCullough, KB Cantrell, BE Zimmerman, DM Carroll, FI
Citation: Jb. Thomas et al., Identification of an opioid kappa receptor subtype-selective N-substituentfor (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine, J MED CHEM, 41(26), 1998, pp. 5188-5197
Risultati: 1-11 |